1. Home
  2. RZLV vs KALV Comparison

RZLV vs KALV Comparison

Compare RZLV & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLV
  • KALV
  • Stock Information
  • Founded
  • RZLV 2016
  • KALV N/A
  • Country
  • RZLV United Kingdom
  • KALV United States
  • Employees
  • RZLV N/A
  • KALV N/A
  • Industry
  • RZLV
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • RZLV
  • KALV Health Care
  • Exchange
  • RZLV NYSE
  • KALV Nasdaq
  • Market Cap
  • RZLV 394.3M
  • KALV 418.1M
  • IPO Year
  • RZLV N/A
  • KALV N/A
  • Fundamental
  • Price
  • RZLV $2.96
  • KALV $8.36
  • Analyst Decision
  • RZLV Strong Buy
  • KALV Strong Buy
  • Analyst Count
  • RZLV 4
  • KALV 6
  • Target Price
  • RZLV $5.50
  • KALV $26.25
  • AVG Volume (30 Days)
  • RZLV 13.2M
  • KALV 421.6K
  • Earning Date
  • RZLV 12-31-2024
  • KALV 12-31-2024
  • Dividend Yield
  • RZLV N/A
  • KALV N/A
  • EPS Growth
  • RZLV N/A
  • KALV N/A
  • EPS
  • RZLV N/A
  • KALV N/A
  • Revenue
  • RZLV $145,051.00
  • KALV N/A
  • Revenue This Year
  • RZLV N/A
  • KALV N/A
  • Revenue Next Year
  • RZLV N/A
  • KALV N/A
  • P/E Ratio
  • RZLV N/A
  • KALV N/A
  • Revenue Growth
  • RZLV 25.96
  • KALV N/A
  • 52 Week Low
  • RZLV $1.57
  • KALV $7.98
  • 52 Week High
  • RZLV $14.50
  • KALV $16.88
  • Technical
  • Relative Strength Index (RSI)
  • RZLV N/A
  • KALV 36.75
  • Support Level
  • RZLV N/A
  • KALV $8.48
  • Resistance Level
  • RZLV N/A
  • KALV $9.30
  • Average True Range (ATR)
  • RZLV 0.00
  • KALV 0.65
  • MACD
  • RZLV 0.00
  • KALV -0.06
  • Stochastic Oscillator
  • RZLV 0.00
  • KALV 17.12

About RZLV REZOLVE AI LTD

Rezolve AI Ltd provides a mobile commerce and engagement platform, underpinned by machine learning, that enables retailers, brands and manufacturers to engage with consumers in a broad range of locations and settings via their mobile devices and personal computers. its platform allows for mobile engagement with merchants using its software to extend their business to consumers' mobile devices and computers in different ways.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

Share on Social Networks: